ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 2456

$699K Total Retail Price of All Prescriptions

Rank: 107 out of 2456

301 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 14,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 802 793 1 1
OMEPRAZOLE 709 658 2 3
METOPROLOL SUCCINATE 646 626 3 13
HYDROCHLOROTHIAZIDE 638 627 4 7
AMLODIPINE BESYLATE 624 610 5 5
SIMVASTATIN 608 592 6 2
ATORVASTATIN CALCIUM 597 584 7 12
LEVOTHYROXINE SODIUM 397 377 8 4
ATENOLOL 388 372 9 6
CRESTOR 378 363 10 25
DIOVAN 375 364 11 26
FUROSEMIDE 350 347 12 8
NIFEDIPINE ER 321 309 13 61
ALENDRONATE SODIUM 301 286 14 19
ZOLPIDEM TARTRATE 288 288 15 28
METOPROLOL TARTRATE 277 277 16 10
WARFARIN SODIUM 214 214 17 9
NEXIUM 202 201 18 80
METFORMIN HCL 200 200 19 11
ENALAPRIL MALEATE 184 173 20 70
ALLOPURINOL 180 156 21 27
LIPITOR 177 176 22 63
ISOSORBIDE MONONITRATE ER 160 160 23 48
CITALOPRAM HBR 156 153 24 14
LIDODERM 149 145 25 58
JANUVIA 134 132 26 81
DONEPEZIL HCL 117 117 27 23
CREON 108 98 28 251
LOSARTAN POTASSIUM 104 104 29 18
GABAPENTIN 98 98 30 16
PANTOPRAZOLE SODIUM 96 96 31 37
PROPRANOLOL HCL 94 90 32 108
MECLIZINE HCL 87 87 33 107
METFORMIN HCL ER 85 85 34 59
LACTULOSE 85 84 34 88
TORSEMIDE 84 81 36 146
FLUTICASONE PROPIONATE 81 80 37 30
TAMSULOSIN HCL 76 76 38 32
PROAIR HFA 76 64 38 22
LOVAZA 75 75 40 219
ACTONEL 75 75 40 252
NITROSTAT 75 71 40 169
PAROXETINE HCL 73 73 43 56
TRAMADOL HCL 73 72 43 24
GLIPIZIDE ER 70 70 45 89
VOLTAREN 69 67 46 241
LOVASTATIN 67 63 47 34
NAMENDA 66 66 48 42
CLOPIDOGREL 64 64 49 55
TRIAMTERENE-HCTZ 63 63 50 53
FINASTERIDE 56 56 51 66
DOXAZOSIN MESYLATE 54 54 52 71
SERTRALINE HCL 53 52 53 21
ECONAZOLE NITRATE 53 53 53 394
ZALEPLON 51 48 55 486
GLIPIZIDE 51 45 55 46
HYDRALAZINE HCL 50 49 57 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.